Skip to main
USPH
USPH logo

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy Inc. has demonstrated a positive financial trajectory, evidenced by a sequential increase in commercial pricing of 2.2%, which is indicative of stable pricing power in its services despite operational challenges in Michigan. Additionally, the company has achieved a notable 22.2% growth in Industrial Injury Prevention (IIP) revenue overall, and an 18.4% increase when excluding contributions from mergers and acquisitions, underscoring strong operational performance in this segment. Furthermore, the recent improvement in the net rate for the acquired Metro business, increasing to $107.50 from approximately $101, suggests ongoing enhancements in operational efficiency and revenue generation capabilities.

Bears say

US Physical Therapy Inc has experienced a slight decline in a key financial metric, with a decrease of 0.6% to $83.95 compared to the prior year's figure. The company has been negatively impacted by consistent reimbursement cuts over the last five years, amounting to a cumulative $20 million reduction in profitability. Additionally, operating expenses, including rent and contract labor, exceeded estimates, coming in at 20.2% of revenue, which could further strain the firm's financial performance.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $107.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $107.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.